Berberine alleviates liver fibrosis through inducing ferrous redox to activate ROS-mediated hepatic stellate cells ferroptosis
Abstract Berberine (BBR) has been explored as a potential anti-liver fibrosis agent, but the underlying mechanisms are unknown. In the current study, we aimed to investigate the molecular mechanisms underlying the effect of BBR against liver fibrogenesis in thioacetamide (TAA) and carbon tetrachlori...
Guardado en:
Autores principales: | Jiazhi Yi, Shuyun Wu, Siwei Tan, Yunfei Qin, Xing Wang, Jie Jiang, Huiling Liu, Bin Wu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e20b2c9dbc22437d8bca7f0f63a74de5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Emerging Pathological Engagement of Ferroptosis in Gut Diseases
por: Weihua Gao, et al.
Publicado: (2021) -
γ-Glutamylcysteine Alleviates Ischemic Stroke-Induced Neuronal Apoptosis by Inhibiting ROS-Mediated Endoplasmic Reticulum Stress
por: Hui-qin Li, et al.
Publicado: (2021) -
Exploration of Redox-Related Molecular Patterns and the Redox Score for Prostate Cancer
por: Yue Wu, et al.
Publicado: (2021) -
Initiation of hepatic stellate cell activation extends into chronic liver disease
por: Vincent De Smet, et al.
Publicado: (2021) -
Targeting Ferroptosis: Pathological Mechanism and Treatment of Ischemia-Reperfusion Injury
por: Xinye Li, et al.
Publicado: (2021)